Brodie Nolan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Brodie Nolan has a total of 197 co-authors. Here are the top co-authors by number of shared publications:
Melissa McGowan
Department of Emergency Medicine, St. Michael’s Hospital, Unity Health Toronto, Toronto, Canada
13 shared publicationsBruce Sawadsky
Ornge, Mississauga, Ontario, Canada; Department of Emergency Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
8 shared publicationsIan R. Drennan
Department of Emergency Services and Sunnybrook Research Institute, Sunnybrook Health Science Center, Toronto, Canada
7 shared publicationsAlun Ackery
Department of Medicine,University of Toronto,Toronto,ON
6 shared publications- Andrew Beckett
St. Michael's Hospital Toronto Ontario Canada
6 shared publications Homer Tien
Sunnybrook Health Sciences Centre, Department of Surgery, University of Toronto
6 shared publications
Latest Publications
- Open Access
- 8 November 2026
- Published by Wiley in Transfusion
Utilization of blood in patients with gunshot wounds: A Canadian single‐center experience
Background: Blood product utilization among gunshot wound (GSW) victims has not been characterized in Canada. This study describes transfusion requirements in GSW patients treated at a major Canadian Level‐1 urban trauma center. Study Design and Methods: A retrospective review of a hospital trauma registry in Toronto, Canada, identified GSW patients between 2017 and 2021. Patients under 16, those refusing transfusions, and patients with Absent Vital Signs for whom resuscitation was not initiated were excluded. Total and component‐specific transfusions of red blood cells (RBC), plasma, and platelets were analyzed across hospital stay. Results: Of 5452 trauma team activations, 5% were GSWs ( n = 275; 91.3% male, n = 251; median age 26; overall mortality 14.9%, n = 41). Overall, 77 patients (28%) received 1134 units of blood components while 198 patients (72%) did not require any transfusions. Among those who required transfusions, the average number of blood product units (RBC, plasma, and platelets combined) per patient was 14.47. Transfusions included 716 RBC units, 344 plasma units, and 74 platelet pools. Consumption was markedly skewed: 18 patients (6.5%) who required at least 10 units consumed 70.5% of RBCs, 3.3% ( n = 9) received 72.7% of plasma, and 1.1% ( n = 3) used 59.5% of platelets. Discussion: In this 5‐year review, although GSWs account for a minority of trauma activations, they exert a disproportionate demand on blood inventory, driven heavily by an extreme minority of severely injured patients. Increasing gun violence may further strain the blood supply and recognition of this concentrated utilization pattern is essential for blood bank inventory preparedness, clinical care pathways, and injury prevention strategies.
- 8 November 2026
- Published by Wiley in Transfusion
Open AccessUtilization of blood in patients with gunshot wounds: A Canadian single‐center experience
Background: Blood product utilization among gunshot wound (GSW) victims has not been characterized in Canada. This study describes transfusion requirements in GSW patients treated at a major Canadian Level‐1 urban trauma center. Study Design and Methods: A retrospective review of a hospital trauma registry in Toronto, Canada, identified GSW patients between 2017 and 2021. Patients under 16, those refusing transfusions, and patients with Absent Vital Signs for whom resuscitation was not initiated were excluded. Total and component‐specific transfusions of red blood cells (RBC), plasma, and platelets were analyzed across hospital stay. Results: Of 5452 trauma team activations, 5% were GSWs ( n = 275; 91.3% male, n = 251; median age 26; overall mortality 14.9%, n = 41). Overall, 77 patients (28%) received 1134 units of blood components while 198 patients (72%) did not require any transfusions. Among those who required transfusions, the average number of blood product units (RBC, plasma, and platelets combined) per patient was 14.47. Transfusions included 716 RBC units, 344 plasma units, and 74 platelet pools. Consumption was markedly skewed: 18 patients (6.5%) who required at least 10 units consumed 70.5% of RBCs, 3.3% ( n = 9) received 72.7% of plasma, and 1.1% ( n = 3) used 59.5% of platelets. Discussion: In this 5‐year review, although GSWs account for a minority of trauma activations, they exert a disproportionate demand on blood inventory, driven heavily by an extreme minority of severely injured patients. Increasing gun violence may further strain the blood supply and recognition of this concentrated utilization pattern is essential for blood bank inventory preparedness, clinical care pathways, and injury prevention strategies.
- 8 October 2026
- Published by Springer Nature in Canadian Journal of Emergency Medicine
- p. 1-9
Performance of updated American College of Surgeons field triage guidelines in identifying need for trauma center care
Objective The Guidelines for the Field Triage of injured patients were updated in 2021 to improve the reliability of prehospital trauma triage. The objective of this study was to describe the association of the 2021 Field Triage Guidelines criteria with need for advanced trauma center care from a cohort of patients transported to a level 1 trauma center. Methods This was a health records review of Field Triage Guidelines criteria met for trauma team activations at a level 1 trauma center from January 2020 to December 2021. Hospital-based and injury severity score (ISS)-based trauma center need were defined and sensitivity and specificity of the Field Triage Guidelines calculated for both. Area under the receiver operator curves were used to assess accuracy. Multivariable logistic regression was used to evaluate the association of each criterion with trauma center need. Results A total of 1427 patients were included and 90.3% met at least one Field Triage Guidelines criteria. Overall, patients meeting hospital-based trauma center need was 33.8% compared to 28.4% which met ISS-based trauma center need. Field Triage Guidelines criteria demonstrated a sensitivity of 97.3% and specificity of 13.3% with respect to hospital-based trauma center need with an area under the ROC of 0.80. Mental status and vital signs showed the highest association with trauma center need. Conclusion The updated 2021 Field Triage Guidelines demonstrate good accuracy when assessed retrospectively on a cohort of patients transferred to a level 1 trauma center. The very high sensitivity of the new guidelines may help to reduce undertriage rates to the international goal of <5%. New criteria in this iteration of the Field Triage Guidelines could lead to improved rates of undertriage specifically in severely injured geriatric patients.
- 8 October 2026
- Published by Springer Nature in Canadian Journal of Emergency Medicine
- p. 1-9
Performance of updated American College of Surgeons field triage guidelines in identifying need for trauma center care
Objective The Guidelines for the Field Triage of injured patients were updated in 2021 to improve the reliability of prehospital trauma triage. The objective of this study was to describe the association of the 2021 Field Triage Guidelines criteria with need for advanced trauma center care from a cohort of patients transported to a level 1 trauma center. Methods This was a health records review of Field Triage Guidelines criteria met for trauma team activations at a level 1 trauma center from January 2020 to December 2021. Hospital-based and injury severity score (ISS)-based trauma center need were defined and sensitivity and specificity of the Field Triage Guidelines calculated for both. Area under the receiver operator curves were used to assess accuracy. Multivariable logistic regression was used to evaluate the association of each criterion with trauma center need. Results A total of 1427 patients were included and 90.3% met at least one Field Triage Guidelines criteria. Overall, patients meeting hospital-based trauma center need was 33.8% compared to 28.4% which met ISS-based trauma center need. Field Triage Guidelines criteria demonstrated a sensitivity of 97.3% and specificity of 13.3% with respect to hospital-based trauma center need with an area under the ROC of 0.80. Mental status and vital signs showed the highest association with trauma center need. Conclusion The updated 2021 Field Triage Guidelines demonstrate good accuracy when assessed retrospectively on a cohort of patients transferred to a level 1 trauma center. The very high sensitivity of the new guidelines may help to reduce undertriage rates to the international goal of <5%. New criteria in this iteration of the Field Triage Guidelines could lead to improved rates of undertriage specifically in severely injured geriatric patients.
- Open Access
- 28 September 2026
- Published by Wiley in Transfusion
Early plasma administration in traumatic brain injuries: A systematic review
Background: Early plasma may improve trauma resuscitation by addressing shock and coagulopathy, but its role in traumatic brain injury (TBI) remains uncertain. This systematic review evaluated early plasma in TBI. Methods: This review followed Cochrane methodology and was registered in PROSPERO (CRD420261357882). MEDLINE, Embase, Cochrane databases, and Web of Science were searched on February 3, 2026 and rerun August 11, 2026. Comparative studies of prehospital or early in‐hospital plasma in TBI were eligible. Risk of bias was assessed using RoB‐2 and ROBINS‐I, certainty using GRADE, and findings were synthesized narratively. Results: Fifteen studies including 183,253 patients were included. Studies varied in design, population, plasma product, timing, dose, comparator, and outcomes. A secondary analysis of a cluster‐randomized trial found lower 24‐h and 30‐day mortality with prehospital plasma among patients at risk of hemorrhagic shock subsequently found to have CT‐confirmed TBI; the association was observed among direct scene transports but not interfacility transfers, suggesting timing relative to injury may be important. Two small early in‐hospital trials showed no mortality benefit; one reported similar mortality with plasma and saline, while the other reported higher mortality and more delayed or new intracranial hematomas with plasma. Observational findings were inconsistent and limited by confounding by indication, with variation by plasma timing, comparator, and TBI severity. Certainty of evidence was very low. Conclusions: Evidence is insufficient to determine whether early plasma benefits or harms patients with TBI. Future randomized trials should standardize indications, time‐to‐plasma, plasma protocols, and outcomes and clarify clinically relevant plasma timing windows.
- 28 September 2026
- Published by Wiley in Transfusion
Open AccessEarly plasma administration in traumatic brain injuries: A systematic review
Background: Early plasma may improve trauma resuscitation by addressing shock and coagulopathy, but its role in traumatic brain injury (TBI) remains uncertain. This systematic review evaluated early plasma in TBI. Methods: This review followed Cochrane methodology and was registered in PROSPERO (CRD420261357882). MEDLINE, Embase, Cochrane databases, and Web of Science were searched on February 3, 2026 and rerun August 11, 2026. Comparative studies of prehospital or early in‐hospital plasma in TBI were eligible. Risk of bias was assessed using RoB‐2 and ROBINS‐I, certainty using GRADE, and findings were synthesized narratively. Results: Fifteen studies including 183,253 patients were included. Studies varied in design, population, plasma product, timing, dose, comparator, and outcomes. A secondary analysis of a cluster‐randomized trial found lower 24‐h and 30‐day mortality with prehospital plasma among patients at risk of hemorrhagic shock subsequently found to have CT‐confirmed TBI; the association was observed among direct scene transports but not interfacility transfers, suggesting timing relative to injury may be important. Two small early in‐hospital trials showed no mortality benefit; one reported similar mortality with plasma and saline, while the other reported higher mortality and more delayed or new intracranial hematomas with plasma. Observational findings were inconsistent and limited by confounding by indication, with variation by plasma timing, comparator, and TBI severity. Certainty of evidence was very low. Conclusions: Evidence is insufficient to determine whether early plasma benefits or harms patients with TBI. Future randomized trials should standardize indications, time‐to‐plasma, plasma protocols, and outcomes and clarify clinically relevant plasma timing windows.
- 27 May 2026
- Published by Taylor & Francis in Prehospital Emergency Care
- Vol. 30 (6) , 1-8
Beyond blood pressure: The emerging role of wearable doppler ultrasound in prehospital care
Prehospital and critical care transport environments rely heavily on vital sign data to guide clinical decision-making. However, the acquisition of accurate vital signs is challenged by dynamic conditions. These challenges are further compounded in patients presenting with shock, in whom conventional non-invasive monitoring devices are frequently inaccurate, while invasive monitoring techniques are constrained by resource availability and practitioner qualifications. Wearable Doppler ultrasound systems represent a novel approach that may address equipment and practitioner limitations by enabling continuous, non-invasive assessment of central hemodynamic parameters. Although early evidence suggests promise, data gaps remain, representing a key barrier to broader adoption of these devices. Further validation of wearable Doppler systems in prehospital and critical care transport settings is needed to better define their role within clinical workflows and to determine their impact on patient-centered outcomes.
- 27 May 2026
- Published by Taylor & Francis in Prehospital Emergency Care
- Vol. 30 (6) , 1-8
Beyond blood pressure: The emerging role of wearable doppler ultrasound in prehospital care
Prehospital and critical care transport environments rely heavily on vital sign data to guide clinical decision-making. However, the acquisition of accurate vital signs is challenged by dynamic conditions. These challenges are further compounded in patients presenting with shock, in whom conventional non-invasive monitoring devices are frequently inaccurate, while invasive monitoring techniques are constrained by resource availability and practitioner qualifications. Wearable Doppler ultrasound systems represent a novel approach that may address equipment and practitioner limitations by enabling continuous, non-invasive assessment of central hemodynamic parameters. Although early evidence suggests promise, data gaps remain, representing a key barrier to broader adoption of these devices. Further validation of wearable Doppler systems in prehospital and critical care transport settings is needed to better define their role within clinical workflows and to determine their impact on patient-centered outcomes.
- Open Access
- 20 May 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Systematic review and meta-analysis of machine learning models predicting massive hemorrhage protocol in trauma
Timely activation of massive hemorrhage protocols (MHP) is critical to prevent exsanguination and improve survival in trauma patients. Current clinical tools for predicting MHP need have limited sensitivity and moderate specificity. Machine learning (ML) models may enhance early recognition of life-threatening hemorrhage. We conducted a systematic review and meta-analysis of studies that developed or validated ML models to predict MHP need in patients with traumatic injuries (PROSPERO CRD42024574891). Databases searched included MEDLINE, EMBASE, Web of Science, the Cochrane Central Register of Controlled Trials, and LILACS. Risk of bias was assessed with PROBAST, a funnel plot and Deeks’ statistical test, and the GRADE checklist. Of the 4542 abstracts screened, 21 studies (50 ML models) were included. The ML model types with the highest pooled AUROC were random forest (0.89, 95% CI 0.85–0.93), neural networks (0.88, 95% CI 0.83–0.93), and XGBoost Models (0.86, 95% CI 0.80–0.93), all of which commonly outperforming their non-ML comparator. Despite superior discrimination, most ML models lacked robust subgroup performance evaluation, external validation, or feasibility for clinical deployment. The median APPRAISE-AI methodologic quality score was 51 out of 100 (Interquartile range [IQR]: 46, 55). Further, model reporting quality (TRIPOD + AI) was moderate; no study achieved full points across all 27 reporting items. Risk of bias was frequently high or unclear. Thus, pooled performance metrics should be interpreted with caution, as they may be influenced by methodological weaknesses in the underlying studies. These findings underscore the need for more rigorously designed and transparently reported ML studies in trauma care. Realizing the potential of ML for supporting MHP delivery in trauma care will require further collaborative, clinically grounded model development with robust validation, transparent reporting, and a focus on real-world deployment to translate predictive performance into improved patient outcomes. PROSPERO Registration Number: CRD42024574891.
- 20 May 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessSystematic review and meta-analysis of machine learning models predicting massive hemorrhage protocol in trauma
Timely activation of massive hemorrhage protocols (MHP) is critical to prevent exsanguination and improve survival in trauma patients. Current clinical tools for predicting MHP need have limited sensitivity and moderate specificity. Machine learning (ML) models may enhance early recognition of life-threatening hemorrhage. We conducted a systematic review and meta-analysis of studies that developed or validated ML models to predict MHP need in patients with traumatic injuries (PROSPERO CRD42024574891). Databases searched included MEDLINE, EMBASE, Web of Science, the Cochrane Central Register of Controlled Trials, and LILACS. Risk of bias was assessed with PROBAST, a funnel plot and Deeks’ statistical test, and the GRADE checklist. Of the 4542 abstracts screened, 21 studies (50 ML models) were included. The ML model types with the highest pooled AUROC were random forest (0.89, 95% CI 0.85–0.93), neural networks (0.88, 95% CI 0.83–0.93), and XGBoost Models (0.86, 95% CI 0.80–0.93), all of which commonly outperforming their non-ML comparator. Despite superior discrimination, most ML models lacked robust subgroup performance evaluation, external validation, or feasibility for clinical deployment. The median APPRAISE-AI methodologic quality score was 51 out of 100 (Interquartile range [IQR]: 46, 55). Further, model reporting quality (TRIPOD + AI) was moderate; no study achieved full points across all 27 reporting items. Risk of bias was frequently high or unclear. Thus, pooled performance metrics should be interpreted with caution, as they may be influenced by methodological weaknesses in the underlying studies. These findings underscore the need for more rigorously designed and transparently reported ML studies in trauma care. Realizing the potential of ML for supporting MHP delivery in trauma care will require further collaborative, clinically grounded model development with robust validation, transparent reporting, and a focus on real-world deployment to translate predictive performance into improved patient outcomes. PROSPERO Registration Number: CRD42024574891.
- Open Access
- 14 May 2026
- Published by Springer Nature in Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine
- Vol. 34 (S1)
The role of freeze-dried plasma in a world of whole blood: a Canadian prehospital and transport perspective
Background: Hemorrhage is the leading preventable cause of trauma death, and timely transfusion remains a major challenge in Canada, particularly in rural and remote regions where long transport times create “blood deserts.” Whole blood has re-emerged as the gold standard for resuscitation, but donor limitations, short shelf-life, and cold-chain requirements restrict its universal deployment. Role of freeze-dried plasma: Freeze-dried plasma (FDP) offers a complementary solution with unique advantages for Canadian prehospital and transport systems. FDP is pathogen-reduced, shelf-stable for up to two years at room temperature, lightweight, and rapidly reconstituted at the point of care. Evidence from military and civilian studies demonstrates its logistical feasibility and safety, particularly in settings with prolonged transport times. FDP has been successfully integrated into NATO and Canadian Armed Forces operations and is increasingly recognized internationally as a practical adjunct to whole blood. In Canada, heterogeneous access to prehospital transfusion, high wastage rates of thawed plasma, and the inequities faced by Indigenous and remote communities highlight the urgent need for alternative strategies. Conclusion: FDP and whole blood are not competing but rather they are complementary therapies in a prehospital transfusion system. FDP represents a scalable, equitable, and operationally feasible option to extend balanced resuscitation to patients in rural and remote Canada. A coordinated national strategy, including regulatory approval, pilot projects, and outcome evaluation through networks such as CAN-PATT, is essential to move FDP from battlefield innovation to civilian standard of care.
- 14 May 2026
- Published by Springer Nature in Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine
- Vol. 34 (S1)
Open AccessThe role of freeze-dried plasma in a world of whole blood: a Canadian prehospital and transport perspective
Background: Hemorrhage is the leading preventable cause of trauma death, and timely transfusion remains a major challenge in Canada, particularly in rural and remote regions where long transport times create “blood deserts.” Whole blood has re-emerged as the gold standard for resuscitation, but donor limitations, short shelf-life, and cold-chain requirements restrict its universal deployment. Role of freeze-dried plasma: Freeze-dried plasma (FDP) offers a complementary solution with unique advantages for Canadian prehospital and transport systems. FDP is pathogen-reduced, shelf-stable for up to two years at room temperature, lightweight, and rapidly reconstituted at the point of care. Evidence from military and civilian studies demonstrates its logistical feasibility and safety, particularly in settings with prolonged transport times. FDP has been successfully integrated into NATO and Canadian Armed Forces operations and is increasingly recognized internationally as a practical adjunct to whole blood. In Canada, heterogeneous access to prehospital transfusion, high wastage rates of thawed plasma, and the inequities faced by Indigenous and remote communities highlight the urgent need for alternative strategies. Conclusion: FDP and whole blood are not competing but rather they are complementary therapies in a prehospital transfusion system. FDP represents a scalable, equitable, and operationally feasible option to extend balanced resuscitation to patients in rural and remote Canada. A coordinated national strategy, including regulatory approval, pilot projects, and outcome evaluation through networks such as CAN-PATT, is essential to move FDP from battlefield innovation to civilian standard of care.
- Open Access
- 4 May 2026
- Published by Wiley in Transfusion
- Vol. 66 (8) , 1480-1494
Understanding public perspectives of prehospital trauma research: A qualitative community engagement study on consent and blood transfusion
Background: Unintentional injuries are a major cause of death worldwide. Modern trauma systems have reduced morbidity and mortality through rapid prehospital care, yet trauma research faces challenges obtaining informed consent during emergencies. Because patients are often incapacitated and substitute decision makers are unavailable, studies commonly rely on deferred or waived consent. Despite their use, little is known about public perspectives on these models or on prehospital interventions such as paramedic‐administered blood transfusion. Objective: To explore Canadian public perspectives on trauma research, alternative consent models, and prehospital blood transfusion. Methods: A multi‐methods community engagement study, including a national survey and 96 in situ interviews in four rural Ontario communities. Survey and interview questions assessed trust in healthcare, views on research consent, and acceptance of prehospital blood transfusion. Quantitative data were summarized descriptively; qualitative data underwent thematic analysis. Results: Survey respondents reported strong trust in the healthcare system (75%) and support for clinical trials (80%). Acceptance of alternative consent was mixed, with only 40% finding it acceptable. Most agreed that data collected before withdrawal of consent should remain usable. Support for paramedic‐administered blood transfusion was high (70%), grounded in urgency and trust in paramedic expertise, though concerns included safety and autonomy. Interviews reinforced these themes, emphasizing conditional acceptance of deferred consent, preference for timely communication, and strong trust in paramedics during life‐threatening emergencies. Conclusion: Canadians support prehospital blood transfusion and recognize the need for trauma research, but acceptance of alternative consent models depends on transparency, perceived necessity, and respect for autonomy.
- 4 May 2026
- Published by Wiley in Transfusion
- Vol. 66 (8) , 1480-1494
Open AccessUnderstanding public perspectives of prehospital trauma research: A qualitative community engagement study on consent and blood transfusion
Background: Unintentional injuries are a major cause of death worldwide. Modern trauma systems have reduced morbidity and mortality through rapid prehospital care, yet trauma research faces challenges obtaining informed consent during emergencies. Because patients are often incapacitated and substitute decision makers are unavailable, studies commonly rely on deferred or waived consent. Despite their use, little is known about public perspectives on these models or on prehospital interventions such as paramedic‐administered blood transfusion. Objective: To explore Canadian public perspectives on trauma research, alternative consent models, and prehospital blood transfusion. Methods: A multi‐methods community engagement study, including a national survey and 96 in situ interviews in four rural Ontario communities. Survey and interview questions assessed trust in healthcare, views on research consent, and acceptance of prehospital blood transfusion. Quantitative data were summarized descriptively; qualitative data underwent thematic analysis. Results: Survey respondents reported strong trust in the healthcare system (75%) and support for clinical trials (80%). Acceptance of alternative consent was mixed, with only 40% finding it acceptable. Most agreed that data collected before withdrawal of consent should remain usable. Support for paramedic‐administered blood transfusion was high (70%), grounded in urgency and trust in paramedic expertise, though concerns included safety and autonomy. Interviews reinforced these themes, emphasizing conditional acceptance of deferred consent, preference for timely communication, and strong trust in paramedics during life‐threatening emergencies. Conclusion: Canadians support prehospital blood transfusion and recognize the need for trauma research, but acceptance of alternative consent models depends on transparency, perceived necessity, and respect for autonomy.
- Open Access
- 1 May 2026
- Published by Springer Nature in Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine
- Vol. 34 (S1)
Alternative models of consent in out-of-hospital transfusion trials: a CAN-PATT position statement supporting exception from prospective consent with opt-out notification
Out-of-hospital blood transfusion (OHBT) trials in trauma face unique ethical and operational challenges. Patients are often incapacitated, time-critical interventions preclude traditional consent, and surrogate decision-makers are rarely accessible in the out-of-hospital environment. The Canadian Prehospital and Transport Transfusion Network (CAN-PATT) supports the use of alternative models of consent to enable rigorous evaluation of OHBT strategies. This position statement outlines the ethical and regulatory justification for an exception from prospective consent with opt-out notification model used in the SWiFT Canada (Study of Whole Blood in Frontline Trauma) pilot randomized controlled trial. Grounded in the Tri-Council Policy Statement 2 (TCPS2) Article 3.8 governing research in medical emergencies, the SWiFT Canada model uses multi-modal notification and post-enrollment withdrawal options to balance feasibility with respect for autonomy. We argue this approach is essential to advance evidence-based transfusion practice in Canadian out-of-hospital care and serves as a national template for emergency research.
- 1 May 2026
- Published by Springer Nature in Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine
- Vol. 34 (S1)
Open AccessAlternative models of consent in out-of-hospital transfusion trials: a CAN-PATT position statement supporting exception from prospective consent with opt-out notification
Out-of-hospital blood transfusion (OHBT) trials in trauma face unique ethical and operational challenges. Patients are often incapacitated, time-critical interventions preclude traditional consent, and surrogate decision-makers are rarely accessible in the out-of-hospital environment. The Canadian Prehospital and Transport Transfusion Network (CAN-PATT) supports the use of alternative models of consent to enable rigorous evaluation of OHBT strategies. This position statement outlines the ethical and regulatory justification for an exception from prospective consent with opt-out notification model used in the SWiFT Canada (Study of Whole Blood in Frontline Trauma) pilot randomized controlled trial. Grounded in the Tri-Council Policy Statement 2 (TCPS2) Article 3.8 governing research in medical emergencies, the SWiFT Canada model uses multi-modal notification and post-enrollment withdrawal options to balance feasibility with respect for autonomy. We argue this approach is essential to advance evidence-based transfusion practice in Canadian out-of-hospital care and serves as a national template for emergency research.